Dr. Afshin Eli Gabayan, MD

Expert Publications

• Extended follow-up of a phase 2 trial of bortezomib alone and in combination with dexamethasone for the frontline treatment of multiple myeloma.

Media Releases

Offering a Healing and Supportive Environment with Balanced Cancer Diagnostics and Comprehensive Treatment Options

Beverly Hills, California – Afshin Eli Gabayan, MD, a prominent hematologist-oncologist and the Founder and Medical Director of Beverly Hills Cancer Center, is redefining cancer treatment by integrating state-of-the-art medical care with innovative research. 

At this private, academic facility, patients benefit from a comprehensive range of cancer treatment modalities, all available under one roof. From chemotherapy and radiation therapy to advanced diagnostic imaging and laboratory services, Beverly Hills Cancer Center is a beacon of hope for cancer patients worldwide.

Dr. Gabayan, a 1994 graduate of the prestigious Keck School of Medicine at the University of Southern California, has dedicated his career to advancing cancer treatments. Following his internship and residency at the University of California, Los Angeles (UCLA), where he served as Chief Resident, he honed his expertise in oncology and hematology at Cedars-Sinai Medical Center, where he remained as an attending physician in private practice with expertise in the areas of gastrointestinal, lung, breast cancers and multiple myeloma.

Under Dr. Gabayan’s leadership, Beverly Hills Cancer Center offers patients the unique opportunity to participate in groundbreaking clinical trials that are not widely available. This initiative not only attracts patients from around the globe but also fosters hope through access to the latest advancements in cancer treatment.

At the core of Dr. Gabayan’s practice is a fervent advocacy for advancing medical research for all cancer patients. His dedication to providing the latest therapy options ensures that every patient receives personalized care tailored to their unique needs. This fusion of cutting-edge science and compassionate care has positioned Beverly Hills Cancer Center among the leading cancer treatment facilities in Los Angeles and beyond.

In addition to his medical practice, Dr. Gabayan is deeply committed to his community, regularly delivering lectures on various oncology and hematology topics. His philanthropic efforts, including support for Covenant House, reflect his dedication to making a meaningful impact beyond the walls of the clinic.

Recommended Articles

• 9/11 Ground Zero Worker's Lymphoma Improves with Clinical Trial

  When the terrorist attacks occurred in New York on September 11th, 2001, Bart Zagami, a 61-year-old New York State Supreme Court officer, was in his office just a few blocks away from the World Trade Center in lower Manhattan. Days after the 9/11 terrorist attacks, Zagami spent his time at Ground...

• Bringing Chronic Lymphocytic Leukemia Patients and Their Doctors Together via Survey

  While patients may entirely admire and respect their doctors, sometimes they simply do not agree with the course of action they are proposing. While this may not be a big deal for a visit about a cold or something minimal, it can be life-altering for those with chronic conditions. That is why a...

• Mr. T's Lessons on Life and Lymphoma

  There are several things that Mr. T is known for, including his career as a WWF wrestler and his role as B.A. Baracus in the hit series ‘The A-Team’. To this day, he continues to remain a fun and stylish icon of the 80s. Nevertheless, Mr. T is not only known for his appearances on television,...

• Living as a Hodgkin Lymphoma Survivor: Creating a New Normal

  No one can ever truly be prepared for what it is like to live with cancer. Even the strongest survivors face setbacks, and some of the fiercest warriors share their stories of how they find their "new normals."Kimberly's storyWhen she was only 25, just five days before her wedding, Kimberly felt a...

• The Leukemia & Lymphoma Society to Expand Mission Against Blood Cancer

  On July 19, 2017, the Leukemia & Lymphoma Society, or LLS, proclaimed that they would be expanding their initiative to beat acute myeloid leukemia. Referred to as "Beat AML Master Trial", the project aims to test new and innovative treatments for those suffering from AML. For more information...

• Study Finds 3% of Pediatric Non-Hodgkin Lymphoma Cases Are Transplant Recipients

  Lymphoma is a blood cancer that affects both children and adults.Lymphoma begins its growth in the lymphatic white blood cells of the lymph system. This system is a major warrior in fighting off infections and diseases. It is part of the body’s immunity team.The lymph system loops throughout the...